Real-Life Comparative Effectiveness of IL-23 Inhibitors in the Treatment of Moderate to Severe Psoriasis: A Multicenter Experience. Dermatol Pract Concept [Internet]. 2024 Jul. 31 [cited 2025 Jan. 21];14(3):e2024179. Available from: https://www.dpcj.org/index.php/dpc/article/view/4159